BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311's Superior Market Potential Over Pemgarda

Invivyd Inc. (NASDAQ:IVVD) is one of the best biotech penny stocks to buy according to analysts. On December 22, BTIG analyst Thomas Shrader initiated coverage of Invivyd with a Buy rating and $10 price target. BTIG maintained this stance on Invivyd, citing the company’s established expertise in antibody production. The firm informed investors that VYD2311’s market potential far exceeds that of Pemgarda, which positions the stock for significant growth.

Additionally, on December 23, Invivyd announced two major regulatory and clinical milestones for VYD2311, which is its investigational monoclonal antibody/mAb designed as a vaccine alternative for COVID-19 prevention. The US FDA granted Fast Track designation to VYD2311 for preventing COVID-19 in individuals with underlying risk factors for severe disease.

Simultaneously, Invivyd Inc. (NASDAQ:IVVD) initiated DECLARATION, a pivotal Phase 3, randomized, triple-blind, placebo-controlled clinical trial. This BLA-enabling study will evaluate the safety and efficacy of VYD2311 in preventing symptomatic COVID-19 across a broad population of ~1,770 adults and adolescents. The trial is a key component of Invivyd’s REVOLUTION clinical program, with top-line data expected in mid-2026. Strategically, Invivyd is initiating enrollment during a peak winter infection season to leverage historical trends in COVID-19 attack rates.

Invivyd Inc. (NASDAQ:IVVD) is a biopharmaceutical company that discovers, develops, and commercializes antibody-based solutions for infectious diseases in the US.

While we acknowledge the potential of IVVD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.